These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
936 related articles for article (PubMed ID: 18978032)
1. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Dhar S; Gu FX; Langer R; Farokhzad OC; Lippard SJ Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17356-61. PubMed ID: 18978032 [TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Dhar S; Kolishetti N; Lippard SJ; Farokhzad OC Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1850-5. PubMed ID: 21233423 [TBL] [Abstract][Full Text] [Related]
3. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Kolishetti N; Dhar S; Valencia PM; Lin LQ; Karnik R; Lippard SJ; Langer R; Farokhzad OC Proc Natl Acad Sci U S A; 2010 Oct; 107(42):17939-44. PubMed ID: 20921363 [TBL] [Abstract][Full Text] [Related]
4. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Cheng J; Teply BA; Sherifi I; Sung J; Luther G; Gu FX; Levy-Nissenbaum E; Radovic-Moreno AF; Langer R; Farokhzad OC Biomaterials; 2007 Feb; 28(5):869-76. PubMed ID: 17055572 [TBL] [Abstract][Full Text] [Related]
5. Aptamer-modified PLGA nanoparticle delivery of triplex forming oligonucleotide for targeted prostate cancer therapy. Jiao J; Zou Q; Zou MH; Guo RM; Zhu S; Zhang Y Neoplasma; 2016; 63(4):569-75. PubMed ID: 27268920 [TBL] [Abstract][Full Text] [Related]
6. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Farokhzad OC; Cheng J; Teply BA; Sherifi I; Jon S; Kantoff PW; Richie JP; Langer R Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6315-20. PubMed ID: 16606824 [TBL] [Abstract][Full Text] [Related]
7. Plumbagin-loaded aptamer-targeted poly D,L-lactic-co-glycolic acid-b-polyethylene glycol nanoparticles for prostate cancer therapy. Pan M; Li W; Yang J; Li Z; Zhao J; Xiao Y; Xing Y; Zhang X; Ju W Medicine (Baltimore); 2017 Jul; 96(30):e7405. PubMed ID: 28746182 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and Preliminary Biological Assessment of Carborane-Loaded Theranostic Nanoparticles to Target Prostate-Specific Membrane Antigen. Meher N; Seo K; Wang S; Bidkar AP; Fogarty M; Dhrona S; Huang X; Tang R; Blaha C; Evans MJ; Raleigh DR; Jun YW; VanBrocklin HF; Desai TA; Wilson DM; Ozawa T; Flavell RR ACS Appl Mater Interfaces; 2021 Nov; 13(46):54739-54752. PubMed ID: 34752058 [TBL] [Abstract][Full Text] [Related]
9. Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy. Chen Z; Tai Z; Gu F; Hu C; Zhu Q; Gao S Eur J Pharm Biopharm; 2016 Oct; 107():130-41. PubMed ID: 27393562 [TBL] [Abstract][Full Text] [Related]
11. Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy. Wu X; Ding B; Gao J; Wang H; Fan W; Wang X; Zhang W; Wang X; Ye L; Zhang M; Ding X; Liu J; Zhu Q; Gao S Int J Nanomedicine; 2011; 6():1747-56. PubMed ID: 21980237 [TBL] [Abstract][Full Text] [Related]
13. Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. Dhar S; Liu Z; Thomale J; Dai H; Lippard SJ J Am Chem Soc; 2008 Aug; 130(34):11467-76. PubMed ID: 18661990 [TBL] [Abstract][Full Text] [Related]
14. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor. Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181 [TBL] [Abstract][Full Text] [Related]
15. Glutamate-urea-based PSMA-targeted PLGA nanoparticles for prostate cancer delivery of docetaxel. Saniee F; Shabani Ravari N; Goodarzi N; Amini M; Atyabi F; Saeedian Moghadam E; Dinarvand R Pharm Dev Technol; 2021 Apr; 26(4):381-389. PubMed ID: 33538232 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide- Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625 [TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Farokhzad OC; Jon S; Khademhosseini A; Tran TN; Lavan DA; Langer R Cancer Res; 2004 Nov; 64(21):7668-72. PubMed ID: 15520166 [TBL] [Abstract][Full Text] [Related]
18. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells. Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829 [TBL] [Abstract][Full Text] [Related]
19. Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells. Gryparis EC; Hatziapostolou M; Papadimitriou E; Avgoustakis K Eur J Pharm Biopharm; 2007 Aug; 67(1):1-8. PubMed ID: 17303395 [TBL] [Abstract][Full Text] [Related]
20. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Gu F; Zhang L; Teply BA; Mann N; Wang A; Radovic-Moreno AF; Langer R; Farokhzad OC Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2586-91. PubMed ID: 18272481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]